Skip to main content

CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery.

Benns HJ, Storch M, Falco JA, Fisher FR, Tamaki F, Alves E, Wincott CJ, Milne R, Wiedemar N, Craven G, Baragana B, Wyllie S, Baum J, Baldwin GS, Weerapana E, Tate EW, Child MA
Nat Microbiol. 2022 Nov;7(11):1891-1905. doi: 10.1038/s41564-022-01249-y. Epub 2022 Oct 20. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.

Antibodies from Article